Skip to the page Regenerative Doctor Directory Question cards before regenerative treatment Take questions to a visit Treatment cards What, exactly, is on offer? Get the medicine’s name and the problem it is meant to treat. Ask if it comes as a pill or is given as a shot. Ask. Check. Keep the answer. Name it Ask for the actual medicine. A clinician reviews your health and decides on care; the term means a health professional. Ask them to write down the medicine’s name, how it would be given, and the problem it is meant to treat. Peptides are protein building blocks joined into small chains; insulin is a familiar example. Ask it plainly What is the full name of the treatment, and what are we trying to change? Sort the answer An approval belongs to a product. The FDA is the Food and Drug Administration, the U.S. drug agency. Keep the product name beside any claim about its approval. Evidence card · Product status Ask which use has approval. Semaglutide (Ozempic, Wegovy) has FDA approval for specific uses. Open the source note Ask which use has approval. — source note The approved uses depend on the product and whether it is a tablet or a shot. FDA’s semaglutide product label Ask it plainly Is this exact product approved for my condition, or are you proposing a different use? When the medicine is made for you Ask why an approved option does not fit. Compounding is the name for preparing a patient’s medicine to order; a pharmacist or doctor does this. Evidence card · Made-to-order care Compounding has a role, and limits. A medicine prepared for one patient can serve a need that approved medicines cannot cover. The legal rules for compounding still apply. A compounded medicine has no FDA approval. Open the source note Compounding has a role, and limits. — source note Before a compounded medicine is sold, the FDA has not checked how well it is made, whether it is safe, or whether it works. FDA’s explanation of compounding Ask it plainly What need does this medicine meet that an approved product cannot? If the label says research Ask why it is being offered as care. Evidence card · Research labels The label does not settle the question. Sellers received FDA warning letters for offering products for human use under labels that described them as research products. Open the source note The label does not settle the question. — source note The letters say the sellers broke drug laws. They give the FDA’s position about those businesses; they are not decisions made by a court. FDA’s letter about research labels Keep the label and the page that made the offer. Use the pause cards to work out what remains unanswered. Keep going Check who is behind the offer Keep these guide cards beside you. This site runs no clinic and sells nothing. Facts checked: September 17, 2026; September 26, 2026. Read this page as text Full kit as text Back to the page start Home Treatment Credentials Visit Cost Evidence Pause